A Single Shot That Cuts Your LDL by 62 Percent. The Catch: It Edits Your DNA.
Eli Lilly’s VERVE-102 gene-editing therapy cut LDL by 62 percent at the highest dose in Phase 1, with no treatment-related serious adverse events. It edits a single DNA letter in the PCSK9 gene of liver cells. The effect appears permanent. The trade-off is that you cannot undo it.










